Kimberly Ward, Senior Research Project Manager at Moffitt Cancer Center, shared a post by OncoDaily, adding:
“It was a great day presenting at ASCO26.
I presented on the health related quality of life (HRQoL) following tumor-infiltrating lymphocyte (TIL) therapy with commercial lifileucel in metastatic melanoma.”
Quoting OncoDaily‘s post:
“Poster presentation by Kimberly Ward at American Society of Clinical Oncology (ASCO).”